Annual CFI
-$769.00 K
+$2.84 M+78.70%
31 December 2023
Summary:
Werewolf Therapeutics annual cash flow from investing activities is currently -$769.00 thousand, with the most recent change of +$2.84 million (+78.70%) on 31 December 2023. During the last 3 years, it has fallen by -$271.00 thousand (-54.42%). HOWL annual CFI is now -189.10% below its all-time high of -$266.00 thousand, reached on 31 December 2019.HOWL Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$3000.00
+$14.00 K+82.35%
30 September 2024
Summary:
Werewolf Therapeutics quarterly cash flow from investing activities is currently -$3000.00, with the most recent change of +$14.00 thousand (+82.35%) on 30 September 2024. Over the past year, it has increased by +$195.00 thousand (+98.48%). HOWL quarterly CFI is now at all-time high.HOWL Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$329.00 K
+$218.00 K+39.85%
30 September 2024
Summary:
Werewolf Therapeutics TTM cash flow from investing activities is currently -$329.00 thousand, with the most recent change of +$218.00 thousand (+39.85%) on 30 September 2024. Over the past year, it has increased by +$440.00 thousand (+57.22%). HOWL TTM CFI is now -165.32% below its all-time high of -$124.00 thousand, reached on 31 March 2021.HOWL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOWL Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +98.5% | +57.2% |
| 3 y3 years | -54.4% | +98.9% | +33.9% |
| 5 y5 years | -189.1% | - | - |
HOWL Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -54.4% | +78.7% | at high | +99.8% | at high | +91.2% |
| 5 y | 5 years | -189.1% | +78.7% | at high | +99.8% | -165.3% | +91.2% |
| alltime | all time | -189.1% | +78.7% | at high | +99.8% | -165.3% | +91.2% |
Werewolf Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3000.00(-82.4%) | -$329.00 K(-39.9%) |
| June 2024 | - | -$17.00 K(-84.7%) | -$547.00 K(-23.2%) |
| Mar 2024 | - | -$111.00 K(-43.9%) | -$712.00 K(-7.4%) |
| Dec 2023 | -$769.00 K(-78.7%) | -$198.00 K(-10.4%) | -$769.00 K(-29.4%) |
| Sept 2023 | - | -$221.00 K(+21.4%) | -$1.09 M(-61.4%) |
| June 2023 | - | -$182.00 K(+8.3%) | -$2.82 M(-24.8%) |
| Mar 2023 | - | -$168.00 K(-67.6%) | -$3.75 M(+3.9%) |
| Dec 2022 | -$3.61 M | -$518.00 K(-73.5%) | -$3.61 M(+7.3%) |
| Sept 2022 | - | -$1.95 M(+75.9%) | -$3.37 M(+122.4%) |
| June 2022 | - | -$1.11 M(+3867.9%) | -$1.51 M(+194.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$28.00 K(-89.7%) | -$513.00 K(+3.0%) |
| Dec 2021 | -$498.00 K(-11.1%) | -$272.00 K(+166.7%) | -$498.00 K(+111.9%) |
| Sept 2021 | - | -$102.00 K(-8.1%) | -$235.00 K(+23.7%) |
| June 2021 | - | -$111.00 K(+753.8%) | -$190.00 K(+53.2%) |
| Mar 2021 | - | -$13.00 K(+44.4%) | -$124.00 K(-77.9%) |
| Dec 2020 | -$560.00 K(+110.5%) | -$9000.00(-84.2%) | -$560.00 K(+1.6%) |
| Sept 2020 | - | -$57.00 K(+26.7%) | -$551.00 K(+11.5%) |
| June 2020 | - | -$45.00 K(-90.0%) | -$494.00 K(+10.0%) |
| Mar 2020 | - | -$449.00 K | -$449.00 K |
| Dec 2019 | -$266.00 K | - | - |
FAQ
- What is Werewolf Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly CFI year-on-year change?
- What is Werewolf Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Werewolf Therapeutics?
- What is Werewolf Therapeutics TTM CFI year-on-year change?
What is Werewolf Therapeutics annual cash flow from investing activities?
The current annual CFI of HOWL is -$769.00 K
What is the all time high annual CFI for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual cash flow from investing activities is -$266.00 K
What is Werewolf Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of HOWL is -$3000.00
What is the all time high quarterly CFI for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly cash flow from investing activities is -$3000.00
What is Werewolf Therapeutics quarterly CFI year-on-year change?
Over the past year, HOWL quarterly cash flow from investing activities has changed by +$195.00 K (+98.48%)
What is Werewolf Therapeutics TTM cash flow from investing activities?
The current TTM CFI of HOWL is -$329.00 K
What is the all time high TTM CFI for Werewolf Therapeutics?
Werewolf Therapeutics all-time high TTM cash flow from investing activities is -$124.00 K
What is Werewolf Therapeutics TTM CFI year-on-year change?
Over the past year, HOWL TTM cash flow from investing activities has changed by +$440.00 K (+57.22%)